Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects

NCT02271113 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: GMI-1271
DRUG: Placebo
DRUG: Enoxaparin Sodium (Lovenox®)

Sponsor

GlycoMimetics Incorporated

Collaborators

[object Object]